Glaxo Smith Kline Pharmaceuticals

Type
Internal restructuring
Country
Belgium
Region
Région wallonne; Prov. Brabant wallon; Arr. Nivelles
Location of affected unit(s)
Wavre
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2 - Manufacture of pharmaceutical preparations
45 jobs
Number of planned job losses
Job loss
Announcement Date
26 March 2012
Employment effect (start)
Foreseen end date

Description

British multinational pharmaceutical company Glaxo Smith Kline (GSK) is about to cut 45 jobs at its plant in Wavre. The company has announced the restructuring to its works council and the Renault procedure has been launched. As of March 2012, there is no indication of when the restructuring will take place.

The internal restructuring will take place at one pharmaceutical department which employs 350.

Sources

  • 26 March 2012: La Libre

Citation

Eurofound (2012), Glaxo Smith Kline Pharmaceuticals, Internal restructuring in Belgium, factsheet number 73387, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/73387.